1	Mononuclear	mononuclear	_	_	_	_	_	_	_
2	leukocyte	leukocyte	_	_	_	_	_	_	_
3	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
4	receptor	receptor	_	_	_	_	_	_	_
5	binding	binding	_	_	_	_	_	_	_
6	characteristics	characteristic	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	down-regulation	down-regulation	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	major	major	_	_	_	_	_	_	_
11	depression	depression	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Some	some	_	_	_	_	_	_	_
2	patients	patient	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	major	major	_	_	_	_	_	_	_
5	depressive	depressive	_	_	_	_	_	_	_
6	disorder	disorder	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	MDD	MDD	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	have	have	_	_	_	_	_	_	_
11	elevated	elevate	_	_	_	_	_	_	_
12	plasma	plasma	_	_	_	_	_	_	_
13	cortisol	cortisol	_	_	_	_	_	_	_
14	concentrations	concentration	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	show	show	_	_	_	_	_	_	_
17	failure	failure	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	suppress	suppress	_	_	_	_	_	_	_
20	cortisol	cortisol	_	_	_	_	_	_	_
21	secretion	secretion	_	_	_	_	_	_	_
22	upon	upon	_	_	_	_	_	_	_
23	administration	administration	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	dexamethasone	dexamethasone	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	DEX	DEX	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	yet	yet	_	_	_	_	_	_	_
31	they	they	_	_	_	_	_	_	_
32	do	do	_	_	_	_	_	_	_
33	not	not	_	_	_	_	_	_	_
34	have	have	_	_	_	_	_	_	_
35	Cushingoid	cushingoid	_	_	_	_	_	_	_
36	features	feature	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	study	study	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	represents	represent	_	_	_	_	_	_	_
6	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	GC	GC	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	resistance	resistance	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	[	[	_	_	_	_	_	_	_
13	3H]-DEX-binding	3h]-dex-binding	_	_	_	_	_	_	_
14	assays	assay	_	_	_	_	_	_	_
15	were	be	_	_	_	_	_	_	_
16	used	use	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	measure	measure	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	vitro	vitro	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	GC	GC	_	_	_	_	_	_	_
25	receptor	receptor	_	_	_	_	_	_	_
26	affinity	affinity	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	1/Kd	1/kd	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	number	number	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	Bmax	Bmax	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	mononuclear	mononuclear	_	_	_	_	_	_	_
37	leukocytes	leukocyte	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	11	11	_	_	_	_	_	_	_
40	MDD	MDD	_	_	_	_	_	_	_
41	patients	patient	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	15	15	_	_	_	_	_	_	_
44	control	control	_	_	_	_	_	_	_
45	subjects	subject	_	_	_	_	_	_	_
46	.	.	_	_	_	_	_	_	_

1	No	no	_	_	_	_	_	_	_
2	receptor	receptor	_	_	_	_	_	_	_
3	abnormalities	abnormality	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	detected	detect	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	MDD	MDD	_	_	_	_	_	_	_
9	group	group	_	_	_	_	_	_	_
10	;	;	_	_	_	_	_	_	_
11	thus	thus	_	_	_	_	_	_	_
12	any	any	_	_	_	_	_	_	_
13	cellular	cellular	_	_	_	_	_	_	_
14	defect	defect	_	_	_	_	_	_	_
15	leading	lead	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	lack	lack	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	responsiveness	responsiveness	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	GC	GC	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	MDD	MDD	_	_	_	_	_	_	_
26	patients	patient	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	if	if	_	_	_	_	_	_	_
29	present	present	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	probably	probably	_	_	_	_	_	_	_
32	lies	lie	_	_	_	_	_	_	_
33	beyond	beyond	_	_	_	_	_	_	_
34	the	the	_	_	_	_	_	_	_
35	initial	initial	_	_	_	_	_	_	_
36	receptor	receptor	_	_	_	_	_	_	_
37	binding	binding	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	DEX	DEX	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	1.0	1.0	_	_	_	_	_	_	_
4	mg	mg	_	_	_	_	_	_	_
5	orally	orally	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	administered	administer	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	study	study	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	vivo	vivo	_	_	_	_	_	_	_
13	GC	GC	_	_	_	_	_	_	_
14	receptor	receptor	_	_	_	_	_	_	_
15	down-regulation	down-regulation	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Compared	compare	_	_	_	_	_	_	_
2	to	to	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	control	control	_	_	_	_	_	_	_
5	group	group	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	fewer	few	_	_	_	_	_	_	_
8	depressed	depressed	_	_	_	_	_	_	_
9	subjects	subject	_	_	_	_	_	_	_
10	down-regulated	down-regulate	_	_	_	_	_	_	_
11	Bmax	Bmax	_	_	_	_	_	_	_
12	after	after	_	_	_	_	_	_	_
13	DEX	DEX	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	paired	paired	_	_	_	_	_	_	_
3	t-test	t-test	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	Bmax	Bmax	_	_	_	_	_	_	_
6	decreased	decrease	_	_	_	_	_	_	_
7	significantly	significantly	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	control	control	_	_	_	_	_	_	_
11	group	group	_	_	_	_	_	_	_
12	but	but	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	depressed	depressed	_	_	_	_	_	_	_
17	group	group	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Receptor	receptor	_	_	_	_	_	_	_
2	number	number	_	_	_	_	_	_	_
3	on	on	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	control	control	_	_	_	_	_	_	_
6	day	day	_	_	_	_	_	_	_
7	did	do	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	correlate	correlate	_	_	_	_	_	_	_
10	significantly	significantly	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	degree	degree	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	down-regulation	down-regulation	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	severity	severity	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	depression	depression	_	_	_	_	_	_	_
21	or	or	_	_	_	_	_	_	_
22	cortisol	cortisol	_	_	_	_	_	_	_
23	concentrations	concentration	_	_	_	_	_	_	_
24	across	across	_	_	_	_	_	_	_
25	all	all	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	subjects	subject	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	do	do	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	lend	lend	_	_	_	_	_	_	_
6	support	support	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	previous	previous	_	_	_	_	_	_	_
9	reports	report	_	_	_	_	_	_	_
10	suggesting	suggest	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	GC	GC	_	_	_	_	_	_	_
13	resistance	resistance	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	MDD	MDD	_	_	_	_	_	_	_
16	results	result	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	GC	GC	_	_	_	_	_	_	_
20	receptor-binding	receptor-binding	_	_	_	_	_	_	_
21	abnormality	abnormality	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	they	they	_	_	_	_	_	_	_
25	emphasize	emphasize	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	importance	importance	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	considering	consider	_	_	_	_	_	_	_
30	receptor	receptor	_	_	_	_	_	_	_
31	studies	study	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	context	context	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	GC-mediated	gc-mediated	_	_	_	_	_	_	_
37	cell	cell	_	_	_	_	_	_	_
38	processes	process	_	_	_	_	_	_	_
39	in	in	_	_	_	_	_	_	_
40	order	order	_	_	_	_	_	_	_
41	to	to	_	_	_	_	_	_	_
42	identify	identify	_	_	_	_	_	_	_
43	the	the	_	_	_	_	_	_	_
44	exact	exact	_	_	_	_	_	_	_
45	cellular	cellular	_	_	_	_	_	_	_
46	defect(s)	defect(s)	_	_	_	_	_	_	_
47	leading	lead	_	_	_	_	_	_	_
48	to	to	_	_	_	_	_	_	_
49	GC	GC	_	_	_	_	_	_	_
50	resistance	resistance	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

